FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2500888904> ?p ?o ?g. }

• W2500888904 endingPage "12803" @default.
• W2500888904 startingPage "12791" @default.
• W2500888904 abstract "Hepatocellular carcinoma (HCC) is a highly vascular tumor with high microvessel density and high levels of circulating vascular endothelial growth factor (VEGF). Thus, the angiogenesis pathway is an attractive therapeutic target for HCC. The anti-tumor effects of evodiamine, a quinolone alkaloid isolated from Euodia rutaecarpa (Juss.) Benth. (Rutaceae), were investigated in a mouse xenograft model using BALB/c nude mice, various HCC cell lines (HepG2, SMMC-7721, H22), and human umbilical vein endothelial cells (HUVECs). The effects of evodiamine on tumor volumes and weights, levels of tumor markers, angiogenesis in vivo and in vitro, cell viability, and cell migration and invasion were measured, and the mechanism through which its effects are achieved was investigated. Transcriptional regulation of VEGFa via interaction with β-catenin was established by luciferase activity assays and electrophoretic mobility shift assays. In a subcutaneous H22 xenograft model, evodiamine inhibited tumor growth and reduced serum tumor markers and the levels of β-catenin and VEGFa. It also blocked VEGF-induced angiogenesis in a Matrigel plug assay. Evodiamine suppressed cellular proliferation, invasion, and migration and inhibited tube formation of HUVECs. Moreover, in a concentration-dependent manner, evodiamine reduced the number of capillary sprouts from Matrigel-embedded rat thoracic aortic rings. Also, evodiamine suppressed various biomarkers of angiogenesis and the expression of β-catenin. Evodiamine decreased β-catenin levels activated by LiCl, which led to reduced expression of VEGFa. In addition, β-catenin interacted with VEGFa and transcriptionally regulated VEGFa, an effect inhibited by evodiamine in HCCs. Moreover, in an SMMC-7721 xenograft model, evodiamine suppressed tumor growth, various biomarkers of angiogenesis, and the levels of β-catenin and VEGFa. Evodiamine has anti-tumor effects on HCCs through inhibiting β-catenin, which interacts with and reduces VEGFa expression, thus inhibiting angiogenesis. These results indicate that evodiamine, which inhibits cellular invasion and migration and blocks angiogenesis, is a potential therapeutic agent for HCCs." @default.
• W2500888904 created "2016-08-23" @default.
• W2500888904 creator A5002112806 @default.
• W2500888904 creator A5008659449 @default.
• W2500888904 creator A5038567341 @default.
• W2500888904 creator A5052274720 @default.
• W2500888904 creator A5063088081 @default.
• W2500888904 creator A5079652041 @default.
• W2500888904 creator A5086818507 @default.
• W2500888904 date "2016-07-23" @default.
• W2500888904 modified "2023-10-18" @default.
• W2500888904 title "Evodiamine exerts anti-tumor effects against hepatocellular carcinoma through inhibiting β-catenin-mediated angiogenesis" @default.
• W2500888904 cites W1114540074 @default.
• W2500888904 cites W122369139 @default.
• W2500888904 cites W1528831599 @default.
• W2500888904 cites W1585205230 @default.
• W2500888904 cites W1827264465 @default.
• W2500888904 cites W1971003978 @default.
• W2500888904 cites W1973867190 @default.
• W2500888904 cites W1978347107 @default.
• W2500888904 cites W1979306439 @default.
• W2500888904 cites W1980856461 @default.
• W2500888904 cites W1985125414 @default.
• W2500888904 cites W1986061180 @default.
• W2500888904 cites W1987562992 @default.
• W2500888904 cites W1988892374 @default.
• W2500888904 cites W1994735619 @default.
• W2500888904 cites W1995111222 @default.
• W2500888904 cites W1997223331 @default.
• W2500888904 cites W2000292756 @default.
• W2500888904 cites W2001741750 @default.
• W2500888904 cites W2001757030 @default.
• W2500888904 cites W2006428522 @default.
• W2500888904 cites W2015588686 @default.
• W2500888904 cites W2016809716 @default.
• W2500888904 cites W2018659577 @default.
• W2500888904 cites W2022234182 @default.
• W2500888904 cites W2023160025 @default.
• W2500888904 cites W2028063907 @default.
• W2500888904 cites W2032269981 @default.
• W2500888904 cites W2032995169 @default.
• W2500888904 cites W2034026025 @default.
• W2500888904 cites W2040425436 @default.
• W2500888904 cites W2041643931 @default.
• W2500888904 cites W2049094442 @default.
• W2500888904 cites W2077767418 @default.
• W2500888904 cites W2079778876 @default.
• W2500888904 cites W2086996641 @default.
• W2500888904 cites W2088575486 @default.
• W2500888904 cites W2089915548 @default.
• W2500888904 cites W2094632857 @default.
• W2500888904 cites W2106787323 @default.
• W2500888904 cites W2113782498 @default.
• W2500888904 cites W2127289044 @default.
• W2500888904 cites W2128378329 @default.
• W2500888904 cites W2128571884 @default.
• W2500888904 cites W2129566023 @default.
• W2500888904 cites W2139519172 @default.
• W2500888904 cites W2142760959 @default.
• W2500888904 cites W2157313762 @default.
• W2500888904 cites W2166384691 @default.
• W2500888904 cites W2167280954 @default.
• W2500888904 cites W2172253185 @default.
• W2500888904 cites W2414286768 @default.
• W2500888904 cites W568938955 @default.
• W2500888904 doi "https://doi.org/10.1007/s13277-016-5251-3" @default.
• W2500888904 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27449032" @default.
• W2500888904 hasPublicationYear "2016" @default.
• W2500888904 type Work @default.
• W2500888904 sameAs 2500888904 @default.
• W2500888904 citedByCount "46" @default.
• W2500888904 countsByYear W25008889042017 @default.
• W2500888904 countsByYear W25008889042018 @default.
• W2500888904 countsByYear W25008889042019 @default.
• W2500888904 countsByYear W25008889042020 @default.
• W2500888904 countsByYear W25008889042021 @default.
• W2500888904 countsByYear W25008889042022 @default.
• W2500888904 countsByYear W25008889042023 @default.
• W2500888904 crossrefType "journal-article" @default.
• W2500888904 hasAuthorship W2500888904A5002112806 @default.
• W2500888904 hasAuthorship W2500888904A5008659449 @default.
• W2500888904 hasAuthorship W2500888904A5038567341 @default.
• W2500888904 hasAuthorship W2500888904A5052274720 @default.
• W2500888904 hasAuthorship W2500888904A5063088081 @default.
• W2500888904 hasAuthorship W2500888904A5079652041 @default.
• W2500888904 hasAuthorship W2500888904A5086818507 @default.
• W2500888904 hasConcept C146285616 @default.
• W2500888904 hasConcept C167734588 @default.
• W2500888904 hasConcept C185592680 @default.
• W2500888904 hasConcept C202751555 @default.
• W2500888904 hasConcept C2777025900 @default.
• W2500888904 hasConcept C2777411675 @default.
• W2500888904 hasConcept C2777834122 @default.
• W2500888904 hasConcept C2778608917 @default.
• W2500888904 hasConcept C2779883843 @default.
• W2500888904 hasConcept C2780394083 @default.
• W2500888904 hasConcept C502942594 @default.
• W2500888904 hasConcept C55493867 @default.

• next